These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7909645)

  • 1. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis.
    Rubin R
    Am J Gastroenterol; 1994 May; 89(5):789-91. PubMed ID: 7909645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
    Faintuch J; Mott CB; Machado MC
    Int Surg; 1985; 70(3):271-2. PubMed ID: 2872181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulfasalazine.
    Ribe J; Benkov KJ; Thung SN; Shen SC; LeLeiko NS
    Am J Gastroenterol; 1986 Mar; 81(3):205-8. PubMed ID: 2869683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfasalazine-induced agranulocytosis.
    Jacobson IM; Kelsey PB; Blyden GT; Demirjian ZN; Isselbacher KJ
    Am J Gastroenterol; 1985 Feb; 80(2):118-21. PubMed ID: 2857524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfasalazine-induced fulminant hepatic failure.
    Marinos G; Riley J; Painter DM; McCaughan GW
    J Clin Gastroenterol; 1992 Mar; 14(2):132-5. PubMed ID: 1348259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant hepatic failure, hepatorenal syndrome, and necrotizing pancreatitis after minocycline hepatotoxicity.
    Boudreaux JP; Hayes DH; Mizrahi S; Hussey J; Regenstein F; Balart L
    Transplant Proc; 1993 Apr; 25(2):1873. PubMed ID: 8470208
    [No Abstract]   [Full Text] [Related]  

  • 7. Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature.
    Halmos B; Anastopoulos HT; Schnipper LE; Ballesteros E
    Ann Hematol; 2004 Apr; 83(4):242-6. PubMed ID: 13680174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative).
    Tameda Y; Hamada M; Takase K; Nakano T; Kosaka Y
    Hepatology; 1996 Mar; 23(3):465-70. PubMed ID: 8617425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypersensitivity reaction to sulfasalazine with a clinical picture similar to mononucleosis].
    Foresti V; Tronci M; Ungaro A; Confalonieri F
    Recenti Prog Med; 1988 Sep; 79(9):382-3. PubMed ID: 2904684
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.
    Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S; Matsumoto K; Kitagawa T; Yamamoto J
    Am J Gastroenterol; 1992 Nov; 87(11):1654-7. PubMed ID: 1359782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute pancreatitis caused by salazopyrine. An unusual association].
    Delgado Fontaneda E; García Campos F; Ruiz Rebollo L; Ibarra Peña B; Moretó Canela M
    Rev Esp Enferm Dig; 1991 Jun; 79(6):439-40. PubMed ID: 1680357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.
    Coban S; Ceydilek B; Ekiz F; Erden E; Soykan I
    Ann Pharmacother; 2005 Oct; 39(10):1737-40. PubMed ID: 16105873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
    Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
    Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surface necroses of the skin following sulfasalazine therapy in ulcerative colitis].
    Krakamp B; Beinhoff U; Knöpfle G; Leidig P
    Med Klin (Munich); 1988 Sep; 83(18):611-2. PubMed ID: 2903432
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis].
    Son CN; Lee HL; Joo YW; Lee OY; Han DS; Yoon BC; Choi HS; Hahm JS
    Korean J Gastroenterol; 2008 Sep; 52(3):192-5. PubMed ID: 19077517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of necrotizing pancreatitis by percutaneous necrosectomy after orthotopic liver transplant for paracetamol induced acute liver failure: a case report.
    Lochan R; Charnley RM; French JJ; Al-Mukhtar A; Hudson M; Manas DM; White SA
    Exp Clin Transplant; 2009 Jun; 7(2):110-4. PubMed ID: 19715515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sulfasalazine-induced pulmonary infiltrates and Legionella pneumonia].
    Bielecki JW; Avar S; Joss R
    Schweiz Med Wochenschr; 2000 Jul; 130(29-30):1078-83. PubMed ID: 10971941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatitis after rectal administration of 5-aminosalicylic acid.
    Isaacs KL; Murphy D
    J Clin Gastroenterol; 1990 Apr; 12(2):198-9. PubMed ID: 1969872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute ulcerative colitis--a rare complication of sulfasalazine therapy.
    Ruppin H; Domschke S
    Hepatogastroenterology; 1984 Aug; 31(4):192-3. PubMed ID: 6148297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.